Cardiac bypass haemostasis: putting blood through the mill.
Bevan
D H
DH
Department of Haematology, St George's Hospital, London.
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D016063:Blood Loss, Surgical; D001804:Blood Transfusion, Autologous; D001026:Coronary Artery Bypass / Q000379:methods*; D005342:Fibrinolysis; D006083:Graft Occlusion, Vascular / Q000209:etiology; D006488:Hemostasis, Surgical / Q000379:methods*; D006490:Hemostatics / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010976:Platelet Count; D017713:Platelet Transfusion; D014148:Tranexamic Acid / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D006490:Hemostatics; D014148:Tranexamic Acid; D006493:Heparin; D007611:Aprotinin